The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Leishmaniasis
Abstract
Leishmaniasis is a poverty-related disease with two main clinical forms: visceral leishmaniasis and cutaneous leishmaniasis. An estimated 0·7-1 million new cases of leishmaniasis per year are reported from nearly 100 endemic countries. The number of reported visceral leishmaniasis cases has decreased substantially in the past decade as a result of better access to diagnosis and treatment and more intense vector control within an elimination initiative in Asia, although natural cycles in transmission intensity might play a role. In east Africa however, the case numbers of this fatal disease continue to be sustained. Increased conflict in endemic areas of cutaneous leishmaniasis and forced displacement has resulted in a surge in these endemic areas as well as clinics across the world. WHO lists leishmaniasis as one of the neglected tropical diseases for which the development of new treatments is a priority. Major evidence gaps remain, and new tools are needed before leishmaniasis can be definitively controlled.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team (2012) · PLoS ONE · doi:10.1371/journal.pone.0035671 · Cited by 5,141
Leishmaniasis: current situation and new perspectives
Desjeux, P. (2004) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,322
Reithinger, R., Dujardin, J.-C., Louzir, H., Pirmez, C., Alexander, B., & Brooker, S. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70209-8 · Cited by 1,334
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
Alvar, J., Aparicio, P., Aseffa, A., Den Boer, M., Cañavate, C., Dedet, J.-P., Gradoni, L., Ter Horst, R., López-Vélez, R., & Moreno, J. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-07 · Cited by 937
Leishmania and human immunodeficiency virus coinfection: the first 10 years
Alvar, J., Cañavate, C., Gutiérrez-Solar, B., Jiménez, M., Laguna, F., López-Vélez, R., Molina, R., & Moreno, J. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.2.298 · Cited by 736
Sundar, S., More, D. K., Singh, M. K., Singh, V. P., Sharma, S., Makharia, A., Kumar, P. C. K., & Murray, H. W. (2000) · Clinical Infectious Diseases · doi:10.1086/318121 · Cited by 664
Cutaneous leishmaniasis: Immune responses in protection and pathogenesis
Scott, P., & Novais, F. O. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.72 · Cited by 591
Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis
QUINNELL, R. J., & COURTENAY, O. (2009) · Parasitology · doi:10.1017/s0031182009991156 · Cited by 487
Epidemiology of visceral leishmaniasis
Ready, P. (2014) · Clinical Epidemiology · doi:10.2147/clep.s44267 · Cited by 471
Aronson, N., Herwaldt, B. L., Libman, M., Pearson, R., Lopez-Velez, R., Weina, P., Carvalho, E. M., Ephros, M., Jeronimo, S., & Magill, A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw670 · Cited by 458
Cited by
Venugopal, G., Bird, J. T., Washam, C. L., Roys, H., Bowlin, A., Byrum, S. D., & Weinkopff, T. (2022) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0010518 · Cited by 26
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
(2023) · doi:10.1021/acsinfecdis.3c00431 · Cited by 10
Metadata
- Authors
- Burza, S., Croft, S. L., & Boelaert, M.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 392
- Issue
- 10151
- Pages
- 951-970
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4211073781
- Cited by
- 1,913
- References
- 82
- FWCI
- 143.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leishmaniasis. https://app.cochat.ai/papers/10.1016/s0140-6736(18)31204-2
- The paper
- Burza, S., Croft, S. L., & Boelaert, M. (2018). Leishmaniasis. The Lancet. https://doi.org/10.1016/s0140-6736(18)31204-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
